Is the Mounjaro Injection Safe? What the Evidence Actually Shows

What side effects do most people actually experience with the Mounjaro injection?

The most frequently reported effects are digestive in nature. Nausea tops the list, followed by loose stools or constipation, indigestion, reflux, and burping. Headache, fatigue and mild dizziness show up less often; injection-site redness or soreness is also possible. These effects are generally at their worst in the first few days after a new pen is started, or after a dose step-up, and most people find they ease off considerably within one to two weeks as the body adjusts.

The SURMOUNT-1 trial, which involved 2,539 adults over 72 weeks, provided the foundational data the MHRA used when it authorised tirzepatide. Side-effect patterns there matched what is described in the NHS's patient guide to tirzepatide, which is a useful plain-English reference for anyone starting treatment. Symptoms tend to be milder at lower doses, which is part of why the prescribing schedule begins at 2.5 mg, a deliberate buffer for your system before any therapeutic increase.

Rarer effects include gallbladder problems, hair thinning (usually temporary), low mood, and, in people with diabetes, hypoglycaemia if taken alongside certain other medicines. None of these are reasons to avoid the medicine outright, but they are reasons to have a thorough conversation before you start. Our prescribers work through all of them as part of every consultation, a process you can begin by requesting your free assessment here.

When should you get medical help straight away?

This is the section worth reading carefully. Most side effects from the Mounjaro injection are uncomfortable but not dangerous. A handful, however, require prompt attention.

Severe, persistent stomach pain (especially pain that travels through to the back, with or without vomiting) is the key symptom to know. In January 2026, the MHRA issued a Drug Safety Update singling out acute pancreatitis as a known, infrequent but serious risk with GLP-1 and GIP/GLP-1 medicines. If that pattern of pain develops, stop the injection and seek emergency care. Do not wait to see if it passes.

Other situations that need medical attention without delay: signs of an allergic reaction (swelling of the face, throat or tongue; difficulty breathing; hives), symptoms of gallbladder disease (pain in the upper right abdomen, fever, jaundice), and severe vomiting or diarrhoea that persists long enough to cause dehydration. Changes to vision, persistent low mood, or thoughts of self-harm should also be flagged to your prescriber or GP promptly.

If you experience a side effect you weren't expecting, you can report it directly through the MHRA Yellow Card scheme. This is not just for serious reactions, even a mild effect the NHS page doesn't mention is worth logging, because Mounjaro carries a Black Triangle (▼) and post-marketing data genuinely shapes how it is used going forward.

Who should not use the Mounjaro injection, and what does safe use look like in practice?

The injection is not licensed for people under 18. It is not recommended during pregnancy, during breastfeeding, or for anyone actively trying to conceive, if your situation changes after starting treatment, tell your prescriber promptly. A personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN2) rules it out entirely. Existing pancreatitis, certain gastroparesis or other serious gastrointestinal conditions, and combinations with specific other medications all require careful prescriber assessment rather than a blanket yes or no.

For people who do use it, technique matters. Rotating injection sites between the abdomen, thigh and upper arm reduces soreness and helps the medicine absorb consistently. Checking how to confirm you've injected correctly is a practical step many new users find reassuring. Pens must be stored in the fridge at 2–8°C, the Patient Information Leaflet gives the exact room-temperature window if you need it while travelling, so refer to that rather than a general estimate. Disposing of used pens safely with a proper sharps container is also part of responsible use.

One thing our prescribers hear regularly: people are unsure whether to skip a dose if life gets in the way, holidays, a busy week, or simply forgetting because the delivery arrived on a bank holiday Monday. The answer every time is to check your Patient Information Leaflet and, if in doubt, contact your prescriber rather than guessing. That is exactly the kind of question our support team handles seven days a week.

Does the injection being 'safe' mean the same as being safe for you specifically?

Not quite. If you are weighing up whether to start treatment, our guide covering what the Mounjaro injection is and how it works is a good place to build your understanding before speaking to a prescriber. A medicine's authorised safety profile describes what happened across a large, diverse group of trial participants. Your individual picture (your other medications, your medical history, your BMI, your goals) is what the prescriber uses to decide whether that profile is acceptable for you. That is not a box-ticking exercise; it is what the clinical assessment exists to do.

Counterfeit pens add a separate layer of risk. Fake tirzepatide products have been seized in the UK in substantial quantities, some containing entirely different substances. Sourcing from a pharmacy you can verify on the GPhC register is the most straightforward safety check available to any patient, and anyone with broader concerns can also read through our detailed pages on whether Mounjaro injections are safe and on whether the Mounjaro injection is safe specifically for weight loss. At nume, every pen comes through the licensed UK supply chain and is dispensed from our GPhC-registered pharmacy (registration 9012878). Details about how we operate are on our about page. If you'd like to talk through suitability and any concerns with our clinical team, starting a free consultation costs nothing and commits you to nothing.